* Medifast Inc MED.N MED is expected to show a fall in
quarterly revenue when it reports results on August 7.
* The Owings Mills Maryland-based company is expected to
report
a 40.4% decrease in revenue to $270.244 million from $453.33
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. The company's guidance on May 1 2023,
for the period ended June 30, was for revenue between $250.00
million and $270.00 million.
* Refinitiv's mean analyst estimate for Medifast Inc is for
earnings of $1.44 per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Medifast
Inc is
$93, below its last closing price of $98.78.
This summary was machine generated August 5 at 02:00 GMT. All
figures in US dollars unless otherwise stated